WITHDRAWN: The use of nanoparticles in LHRH receptor targeted therapy for cancer
While chemotherapy remains the most effective means of treatment for cancer patients, it has become apparent that more efficient modalities are needed. As an alternative to current methods, which can often be toxic to healthy cells and tissues, we discuss "targeted therapy" as an alternate to conventional chemotherapy.
Sarah E, Norberto, Sham S, Kakar
openaire +2 more sources
Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer. [PDF]
Nayak P +5 more
europepmc +1 more source
Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. [PDF]
Giorgio A +4 more
europepmc +1 more source
Small but mighty: Peptides as next-generation immunotargeting agents in gynecological cancers. [PDF]
Garg P, Krishna M, Singhal SS.
europepmc +1 more source
Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate. [PDF]
Branchaud-Croisetière L +2 more
europepmc +1 more source
High-yield induced ovulation in the adult marsupial fat-tailed dunnart (Sminthopsis crassicaudata). [PDF]
Liu J +4 more
europepmc +1 more source
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study. [PDF]
Valenza C +22 more
europepmc +1 more source
Curcumin and Cancer-Related Inflammation. [PDF]
LeBlanc K, Brewer E, Aggarwal S.
europepmc +1 more source
When Hormones Attack: A Literature Review of Progesterone-Induced Anaphylaxis. [PDF]
Bumbăcea RS +4 more
europepmc +1 more source
The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]
Sánchez ML +5 more
europepmc +1 more source

